Atea Pharmaceuticals Inc (AVIR) financials · $353.7M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Atea Pharmaceuticals Inc (AVIR) $353.7M cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Income | −$180.89M | −$192.95M | |
| Net Income | −$158.35M | −$168.38M | |
| EPS (Diluted) | −$1.94 | — | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $315.22M | $464.67M | |
| Current Assets | $310.99M | $462.36M | |
| Cash & Equivalents | $95.71M | $64.70M | |
| PP&E | $457.00K | $873.00K | |
| Total Liabilities | $39.78M | $25.80M | |
| Current Liabilities | $39.78M | $18.60M | |
| Shareholders' Equity | $275.43M | $438.87M | |
| Retained Earnings | −$522.57M | −$364.22M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$132.03M | −$135.50M | |
| Investing Cash Flow | $188.79M | $56.10M | |
| Financing Cash Flow | −$25.75M | $267.00K | |
| Net Change in Cash | $31.02M | −$79.13M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is AVIR P/E and revenue?
Atea Pharmaceuticals Inc (AVIR) $353.7M cap.
What is AVIR revenue?
AVIR income-statement cache has no revenue figure yet.
Is AVIR profitable?
Atea Pharmaceuticals Inc last cached net income is -$158.3M (FY2025).
What are AVIR total assets?
Atea Pharmaceuticals Inc last cached total assets are $315.2M (FY2025).
What is AVIR free cash flow?
No cached cash-flow row for AVIR yet.
Not investment advice. Figures as reported in company filings, not a live feed.